Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02685397
Title Management of Castration-Resistant Prostate Cancer With Oligometastases
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sir Mortimer B. Davis - Jewish General Hospital
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Triptorelin

Goserelin

Leuprolide

Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
BC CANCER Vancouver Recruiting Vancouver British Columbia V5Z 4E6 Canada Details
CancerCare Manitoba Recruiting Winnipeg Manitoba R3E 0V9 Canada Details
Nova Scotia Cancer Centre Recruiting Halifax Nova Scotia B3H 1V7 Canada Details
Juravinski Cancer Centre Recruiting Hamilton Ontario L8V 5C2 Canada Details
London Regional Cancer Program - London Health Sciences Centre Recruiting London Ontario N6A 5W9 Canada Details
Hopital Charles-Lemoyne Recruiting Longueuil Quebec J4V2H1 Canada Details
Centre Hospitalier de l'Université de Montréal (CHUM) - Hopital Notre Dame Recruiting Montreal Quebec H2L 4M1 Canada Details
McGill University Health Center Recruiting Montreal Quebec H4A 3J1 Canada Details
Jewish General Hospital, McGill University Recruiting Montréal Quebec H3T 1E2 Canada Details
CHU de Quebec-Universite Laval Recruiting Québec Quebec G1R 2J6 Canada Details
Centre Hospitalier régional de Trois-Rivières Recruiting Trois-Rivières Quebec G8Z 3R9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field